Bibliographie (2362)
Review: Management of venous thromboembolism in pregnancy.
lundi, 14 février 2022 02:23 Écrit par Zouhair SouissiManagement of venous thromboembolism in pregnancy – Thrombosis Research Related: Management of high-risk pulmonary embolism in pregnancy. Study: Diagnosis of Pulmonary Embolism During Pregnancy Imaging is the only way to diagnose blood clots in pregnancy Prevention and Treatment of Pregnancy-Associated Venous Thromboembolism: Critical Appraisal of International Guidelines
The post Review: Management of venous thromboembolism in pregnancy. appeared first on Links Medicus.
ED management of the post-laryngectomy patient.
lundi, 14 février 2022 02:23 Écrit par Zouhair SouissiED Management of the Post-Laryngectomy Patient – emDocs
The post ED management of the post-laryngectomy patient. appeared first on Links Medicus.
ERS statement on Long COVID-19 follow-up.
lundi, 14 février 2022 02:23 Écrit par Zouhair SouissiEuropean Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
The post ERS statement on Long COVID-19 follow-up. appeared first on Links Medicus.
RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.4
lundi, 14 février 2022 02:23 Écrit par Zouhair SouissiEffect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text) Commentary: Hypothermia vs. Normothermia for Cardiogenic Shock Patients on VA-ECMO – American College of Cardiology Commentary on Twitter In this RCT, for […]
The post RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15). appeared first on Links Medicus.
Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant.
lundi, 14 février 2022 02:23 Écrit par Zouhair SouissiConflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant – STAT Related: FDA halts use of antibody drugs that don’t work vs. Omicron. Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
The post Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant. appeared first on Links Medicus.
Review: Diagnosis, course and management of hypersensitivity pneumonitis.
vendredi, 11 février 2022 10:46 Écrit par Zouhair SouissiDiagnosis, course and management of hypersensitivity pneumonitis – European Respiratory Review
The post Review: Diagnosis, course and management of hypersensitivity pneumonitis. appeared first on Links Medicus.
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments.
vendredi, 11 février 2022 10:46 Écrit par Zouhair SouissiManagement of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments – European Respiratory Review
The post Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments. appeared first on Links Medicus.
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
vendredi, 11 février 2022 10:46 Écrit par Zouhair SouissiWASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension – European Respiratory Review
The post WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. appeared first on Links Medicus.
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.
vendredi, 11 février 2022 10:46 Écrit par Zouhair SouissiRecovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection – European Respiratory Review
The post Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. appeared first on Links Medicus.
A population-based study in Qatar showed previous infection provided robust protection against reinfection with the alpha, beta, and delta variants of SARS-CoV-2 (approximately 90%). However, protection against reinfection with the omicron variant was low
jeudi, 10 février 2022 12:36 Écrit par Zouhair SouissiProtection against the Omicron Variant from Previous SARS-CoV-2 Infection – New England Journal of Medicine Commentary on Twitter Using a national database in Qatar, investigators found that previous #SARSCoV2 infection provided protection against reinfection that ranged from 85% to 92% for alpha, beta, and delta strains and was approx 60% protective against omicron. #COVID19 […]
The post A population-based study in Qatar showed previous infection provided robust protection against reinfection with the alpha, beta, and delta variants of SARS-CoV-2 (approximately 90%). However, protection against reinfection with the omicron variant was lower (around 60%). appeared first on Links Medicus.
